These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
990 related articles for article (PubMed ID: 16005020)
1. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. Karagiannis ED; Popel AS J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020 [TBL] [Abstract][Full Text] [Related]
2. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes. Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822 [TBL] [Abstract][Full Text] [Related]
3. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779 [TBL] [Abstract][Full Text] [Related]
4. MT1-MMP: a potent modifier of pericellular microenvironment. Itoh Y; Seiki M J Cell Physiol; 2006 Jan; 206(1):1-8. PubMed ID: 15920734 [TBL] [Abstract][Full Text] [Related]
5. Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion. Sato H; Takino T Cancer Sci; 2010 Apr; 101(4):843-7. PubMed ID: 20148894 [TBL] [Abstract][Full Text] [Related]
6. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039 [TBL] [Abstract][Full Text] [Related]
7. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Soini Y; Satta J; Määttä M; Autio-Harmainen H J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152 [TBL] [Abstract][Full Text] [Related]
8. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737 [TBL] [Abstract][Full Text] [Related]
9. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Nakada M; Miyamori H; Yamashita J; Sato H Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672 [TBL] [Abstract][Full Text] [Related]
10. Nascent vessel elongation rate is inversely related to diameter in in vitro angiogenesis. Wood LB; Ge R; Kamm RD; Asada HH Integr Biol (Camb); 2012 Sep; 4(9):1081-9. PubMed ID: 22847074 [TBL] [Abstract][Full Text] [Related]
11. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. van Hinsbergh VW; Koolwijk P Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819 [TBL] [Abstract][Full Text] [Related]
13. Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells. Son KN; Hwang J; Kwon BS; Kim J Biochem Biophys Res Commun; 2006 Feb; 340(2):498-504. PubMed ID: 16378600 [TBL] [Abstract][Full Text] [Related]
14. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. Takino T; Watanabe Y; Matsui M; Miyamori H; Kudo T; Seiki M; Sato H Exp Cell Res; 2006 May; 312(8):1381-9. PubMed ID: 16473349 [TBL] [Abstract][Full Text] [Related]
15. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells. Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316 [TBL] [Abstract][Full Text] [Related]
17. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress. Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284 [TBL] [Abstract][Full Text] [Related]
18. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion. Tomita M; Koike H; Han GD; Shimizu F; Kawachi H Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512 [TBL] [Abstract][Full Text] [Related]
19. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice. Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344 [TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]